Cambridge Investment Research Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.26M | Sell |
4,300
-246
| -5% | -$138K | 0.01% | 1587 |
|
|
2026
Q1 | $2.55M | Sell |
4,546
-545
| -11% | -$349K | 0.01% | 1418 |
|
|
2025
Q4 | $3.44M | Sell |
5,091
-94
| -2% | -$64K | 0.01% | 1138 |
|
|
2025
Q3 | $3.31M | Buy |
5,185
+185
| +4% | +$112K | 0.01% | 1152 |
|
|
2025
Q2 | $2.68M | Buy |
5,000
+361
| +8% | +$173K | 0.01% | 1215 |
|
|
2025
Q1 | $1.95M | Sell |
4,639
-562
| -11% | -$244K | 0.01% | 1375 |
|
|
2024
Q4 | $2.15M | Buy |
5,201
+320
| +7% | +$140K | 0.01% | 1308 |
|
|
2024
Q3 | $2.47M | Sell |
4,881
-556
| -10% | -$270K | 0.01% | 1195 |
|
|
2024
Q2 | $2.65M | Sell |
5,437
-1,501
| -22% | -$754K | 0.01% | 1102 |
|
|
2024
Q1 | $3.75M | Sell |
6,938
-289
| -4% | -$158K | 0.01% | 913 |
|
|
2023
Q4 | $4.01M | Sell |
7,227
-423
| -6% | -$199K | 0.02% | 814 |
|
|
2023
Q3 | $3.35M | Buy |
7,650
+302
| +4% | +$151K | 0.02% | 869 |
|
|
2023
Q2 | $3.69M | Sell |
7,348
-73
| -1% | -$35K | 0.02% | 817 |
|
|
2023
Q1 | $3.71M | Buy |
7,421
+869
| +13% | +$416K | 0.02% | 774 |
|
|
2022
Q4 | $2.67M | Buy |
6,552
+1,001
| +18% | +$389K | 0.01% | 922 |
|
|
2022
Q3 | $1.81M | Buy |
5,551
+886
| +19% | +$325K | 0.01% | 1094 |
|
|
2022
Q2 | $1.64M | Buy |
4,665
+438
| +10% | +$179K | 0.01% | 1149 |
|
|
2022
Q1 | $2.31M | Sell |
4,227
-278
| -6% | -$146K | 0.01% | 1053 |
|
|
2021
Q4 | $2.97M | Buy |
4,505
+417
| +10% | +$262K | 0.01% | 928 |
|
|
2021
Q3 | $2.54M | Sell |
4,088
-1,817
| -31% | -$1.22M | 0.01% | 962 |
|
|
2021
Q2 | $3.73M | Buy |
5,905
+164
| +3% | +$90.6K | 0.02% | 769 |
|
|
2021
Q1 | $2.81M | Buy |
5,741
+197
| +4% | +$98.7K | 0.02% | 835 |
|
|
2020
Q4 | $2.77M | Sell |
5,544
-9
| -0.2% | -$4.03K | 0.02% | 752 |
|
|
2020
Q3 | $2.18M | Buy |
5,553
+2,587
| +87% | +$956K | 0.01% | 760 |
|
|
2020
Q2 | $979K | Sell |
2,966
-319
| -10% | -$92.4K | 0.01% | 1131 |
|
|
2020
Q1 | $796K | Buy |
3,285
+357
| +12% | +$93.2K | 0.01% | 1100 |
|
|
2019
Q4 | $765K | Sell |
2,928
-739
| -20% | -$195K | 0.01% | 1310 |
|
|
2019
Q3 | $997K | Buy |
3,667
+551
| +18% | +$153K | 0.01% | 1069 |
|
|
2019
Q2 | $858K | Sell |
3,116
-346
| -10% | -$85.3K | 0.01% | 1105 |
|
|
2019
Q1 | $774K | Buy |
3,462
+15
| +0.4% | +$3.1K | 0.01% | 1187 |
|
|
2018
Q4 | $641K | Sell |
3,447
-15,161
| -81% | -$3.11M | 0.01% | 1188 |
|
|
2018
Q3 | $4.65M | Sell |
18,608
-1,152
| -6% | -$280K | 0.04% | 390 |
|
|
2018
Q2 | $4.31M | Buy |
19,760
+2,494
| +14% | +$514K | 0.05% | 383 |
|
|
2018
Q1 | $3.31M | Sell |
17,266
-239
| -1% | -$44.1K | 0.04% | 445 |
|
|
2017
Q4 | $2.74M | Buy |
17,505
+131
| +0.8% | +$20.6K | 0.03% | 486 |
|
|
2017
Q3 | $2.7M | Sell |
17,374
-133
| -0.8% | -$21K | 0.04% | 437 |
|
|
2017
Q2 | $2.83M | Buy |
17,507
+1,236
| +8% | +$201K | 0.04% | 397 |
|
|
2017
Q1 | $2.52M | Buy |
16,271
+10,137
| +165% | +$1.4M | 0.04% | 388 |
|
|
2016
Q4 | $719K | Sell |
6,134
-6
| -0.1% | -$685 | 0.01% | 831 |
|
|
2016
Q3 | $692K | Sell |
6,140
-96
| -2% | -$10.1K | 0.01% | 856 |
|
|
2016
Q2 | $579K | Sell |
6,236
-1
| -0% | -$86 | 0.01% | 867 |
|
|
2016
Q1 | $488K | Sell |
6,237
-1,678
| -21% | -$121K | 0.01% | 912 |
|
|
2015
Q4 | $577K | Buy |
7,915
+4,409
| +126% | +$315K | 0.01% | 795 |
|
|
2015
Q3 | $260K | Buy |
3,506
+68
| +2% | +$4.87K | 0.01% | 1099 |
|
|
2015
Q2 | $221K | Buy |
+3,438
| New | +$238K | 0.01% | 1227 |
|
|
2014
Q4 | – | Sell |
-3,410
| Closed | -$201K | – | 1433 |
|
|
2014
Q3 | $201K | Sell |
3,410
-140
| -4% | -$8.85K | 0.01% | 1307 |
|
|
2014
Q2 | $237K | Sell |
3,550
-526
| -13% | -$33.4K | 0.01% | 1114 |
|
|
2014
Q1 | $247K | Buy |
+4,076
| New | +$243K | 0.01% | 1036 |
|
Other funds holding IDXX
Cambridge Investment Research Advisors's IDXX Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its Idexx Laboratories (IDXX) stake by 5.4% in Q2 2026, selling an estimated $138K and leaving 4,300 shares worth $2.26M. The position accounts for 0.01% of the portfolio, ranked #1587.
Cambridge Investment Research Advisors first reported a position in IDXX in Q1 2014 and has held it in 48 quarters since. The position peaked at $4.65M in Q3 2018. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Cambridge Investment Research Advisors held 4,300 shares of Idexx Laboratories worth $2.26M as of Q2 2026.
- Cambridge Investment Research Advisors sold 246 Idexx Laboratories shares in Q2 2026, an estimated $138K.
- Idexx Laboratories made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1587 holding.
- Cambridge Investment Research Advisors first reported a position in Idexx Laboratories in Q1 2014 and has held it in 48 quarters since.
- Cambridge Investment Research Advisors's Idexx Laboratories position peaked at $4.65M in Q3 2018.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.